Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
4.580
-0.010 (-0.22%)
Apr 3, 2025, 4:08 PM HKT
HKG:9989 Market Cap
HKG:9989 has a market cap or net worth of 16.39 billion as of April 4, 2025. Its market cap has increased by 33.25% in one year.
Market Cap
16.39B
Enterprise Value
17.51B
Revenue
5.60B
Ranking
n/a
PE Ratio
23.82
Stock Price
4.58
Market Cap Chart
Since May 6, 2010, HKG:9989's market cap has decreased from 79.74B to 16.39B, a decrease of -79.44%. That is a compound annual growth rate of -10.06%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeiGene | 229.95B |
Hansoh Pharmaceutical Group Company | 145.09B |
JD Health International | 107.67B |
WuXi Biologics | 107.56B |
Innovent Biologics | 81.66B |
Akeso | 78.99B |
Alibaba Health Information Technology | 77.20B |
Sichuan Kelun-Biotech Biopharmaceutical | 70.77B |